IBC Life Sciences
The leading provider of scientific, technological and business information
Main menu
My IBC
Formulation Strategies for Protein Therapeutics
CSS
Event Information
Document Title
Event Overview
The 10th Annual Formulation Strategies conference provides critical updates on industry and regulatory trends and their impact on formulation development - to include solutions to help detect and control subvisible particles, analytical methods, high throughput analysis, informatics, devices/packaging and the impact of Quality by Design.
This meeting, now entering its 10th year, presents over 20 practical case studies that show you how to accelerate and improve your formulation development. The topics presented are determined through extensive, direct research formulation scientists working to overcome the challenges of advanced protein therapeutics and next-generation delivery methods.
Topics to be covered include:
- The Formulator of the Future; Using High Throughput Technologies, Informatics and Rational Design to Accelerate Formulation Development
- Comparability and Characterization Analysis for Formulation Development
- Measuring and Controlling Protein Stability
- Implementing Analytical and Control Steps for Subvisible Particles
- Stability and Production Impacts of High Concentration Protein Formulations
- Special Presentation: A Quality by Design-Based Regulatory Filing
- Formulation Strategies for Vaccines
- Formulation Impacts of Device and Packaging Systems
- Formulation Development for Next Generation Biologics
» Download a copy of the preliminary conference agenda, including confirmed speakers (248K PDF).
Here what past attendees had to say....
"Great job on the planning and execution of conference. Very helpful, also great to meet people in the field."
- Jonathan Clapper, Senior Research Associate, Process Development, Trubion
"The Formulation Strategies conferences provided a comprehensive road map to state of the art formulation opportunities and challenges. It provided a snapshot of the latest industry challenges and methods to address these challenges."
- David Hile, Senior Scientist, Formulation Development, Stryker Biotech
"The IBC conference is a unique opportunity to get an overview of the latest developments in protein formulation with the technical experts from the biotech industry"
- Sylvan Huille, Department Head, Formulation Development, LFB France
"Case studies and specific examples are most helpful to the formula scientist for benchmarking purposes. I appreciated the high number of such presentations at this conference. The interactive breakout sessions were beneficial as well for benchmarking purposes"
- Susan Martin, Senior Principal Scientist, Biologics PGRD, Pfizer
"I commend the IBC staff for putting together a balanced mix of topics including emerging areas in biotherapeutics formulation development and a problem solving session."
- Tapan Das, Ph.D., Senior Principal Scientist, Pfizer Global Biologics
"The conference is a good learning experience for formulation starters - it is excellent overview for starter companies."
- Harold Backus, Manager, Analytical Development, Crucell, The Netherlands
"The conference had outstanding presentations and good discussions. The round table and panel discussions are very useful."
- Nazila Miller, Scientist, PAD, Shire Human Genetic Therapies
"I came to this conference as a relative novice in the formulation field. It was helpful and educational to have topics that were general as well as case studies, to highlight real world problems encountered by formulations researchers."
Bottom menu
Copyright IBC Life Sciences, a part of Informa Life Sciences Group. | Phone: 800.390.4078 | Email: reg@ibcusa.com